Medicina
Facultad
Beaumont Hospital
Dublín, IrlandaPublicaciones en colaboración con investigadores/as de Beaumont Hospital (16)
2023
-
Long-term outcomes of patients with normal fractional flow reserve and thin-cap fibroatheroma
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 13, pp. e1099-e1107
-
Morphological characteristics of lesions with thin cap fibroatheroma-a substudy from the COMBINE (OCT-FFR) trial
European heart journal. Cardiovascular Imaging, Vol. 24, Núm. 5, pp. 687-693
2022
-
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19
Scientific Data, Vol. 9, Núm. 1
-
Thin-Cap Fibroatheroma Rather Than Any Lipid Plaques Increases the Risk of Cardiovascular Events in Diabetic Patients: Insights from the COMBINE OCT-FFR Trial
Circulation: Cardiovascular Interventions, Vol. 15, Núm. 5, pp. E011728
2021
-
Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection
BJS Open
-
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score
British Journal of Surgery, Vol. 19, Núm. 4
-
Outcomes after perioperative SARS-CoV-2 infection in patients with proximal femoral fractures: An international cohort study
BMJ Open, Vol. 11, Núm. 11
2018
-
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals
Clinical Microbiology and Infection, Vol. 24, Núm. 10, pp. 1070-1076
-
Long-term safety of in utero exposure to anti-TNFα drugs for the treatment of inflammatory bowel disease: Results from the multicenter European TEDDY study
American Journal of Gastroenterology, Vol. 113, Núm. 3, pp. 396-403
2012
-
Mortality after surgery in Europe: A 7 day cohort study
The Lancet, Vol. 380, Núm. 9847, pp. 1059-1065
2009
-
Safety and immunogenicity of a new formulation of interferon β-1a (Rebif® New Formulation) in a Phase IIIb study in patients with relapsing multiple sclerosis: 96-week results
Multiple Sclerosis, Vol. 15, Núm. 2, pp. 219-228
2007
-
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: The EVEREST clinical status trials
Journal of the American Medical Association, Vol. 297, Núm. 12, pp. 1332-1343
2005
-
Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of vasopressin antagonism in heart failure: Outcome study with Tolvaptan (EVEREST)
Journal of Cardiac Failure, Vol. 11, Núm. 4, pp. 260-269
2004
-
Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial
Journal of Hypertension, Vol. 22, Núm. 4, pp. 847-857
2000
-
Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension
Circulation, Vol. 102, Núm. 10, pp. 1139-1144
1997
-
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
Lancet, Vol. 350, Núm. 9080, pp. 757-764